| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | CAH Cardinal Health Inc | Mason Stephen M | CEO, Medical Segment | Sell | 61,216 | $80.87 | $4,950,537.92 | -55.5% | -4.9% | +27.2% | |
| Nov 7, 2022 | USPH U S Physical Therapy Inc /nv | Reeve Graham D.66 | COO | Sell | 1,909 | $84.79 | $161,864.11 | -19.1% | +15.5% | -2.1% | |
| Nov 7, 2022 | MD Pediatrix Medical Group, Inc. | Swift James D49 | EVP, Chief Operating Officer | Sell | 24,000 | $15.31 | $367,440.00 | -21.4% | +1.4% | -35.2% | |
| Nov 7, 2022 | LFST Lifestance Health Group, Inc. | Gouk Warren71 | Chief Administrative Officer | Sell | 15,106 | $7.20 | $108,763.20 | -0.3% | -28.3% | -15.2% | |
| Nov 7, 2022 | ADUS Addus Homecare Corp | Allison R Dirk65 | CEO And Chairman | Sell | 12,500 | $109.67 | $1,370,875.84 | -8.1% | -4.4% | -23.7% | |
| Nov 7, 2022 | USPH U S Physical Therapy Inc /nv | Binstein Richard54 | EVP Gen'l Counsel &Secretary | Sell | 904 | $85.86 | $77,617.44 | -11.3% | +15.5% | -2.1% | |
| Nov 7, 2022 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 8,146 | $40.35 | $328,672.76 | -3.1% | -17.2% | -20.7% | |
| Nov 7, 2022 | PGNY Progyny, Inc. | Scott Cheryl68 | Director | Sell | 850 | $40.78 | $34,663.00 | -10.5% | -17.2% | -20.7% | |
| Nov 7, 2022 | COR Cencora, Inc. | Walgreens Boots Alliance, Inc.46 | 10% Owner | Sell | 13,234,153 | $154.60 | $2,046,000,053.80 | -25.0% | -4.3% | +21.4% | |
| Nov 7, 2022 | MOH Molina Healthcare, Inc. | Romney Ronna60 | Director | Sell | 150 | $331.56 | $49,734.00 | -0.9% | -9.6% | +5.6% | |
| Nov 7, 2022 | PGNY Progyny, Inc. | Tpg GP A, LLC77 | 10% Owner | Sell | 750,000 | $38.75 | $29,062,500.00 | -7.5% | -17.2% | -20.7% | |
| Nov 7, 2022 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 32,381 | $40.36 | $1,306,754.87 | -2.5% | -17.2% | -20.7% | |
| Nov 7, 2022 | EHAB Enhabit, Inc. | Rush Gregory S | Director | Buy | 10,000 | $12.67 | $126,713.00 | +67.1% | +10.4% | -34.5% | |
| Nov 7, 2022 | TOI Oncology Institute, Inc. | Havencrest Healthcare Partners, L.P.92 | 10% Owner | Sell | 114,867 | $3.45 | $395,935.76 | -0.3% | -54.0% | -47.0% | |
| Nov 4, 2022 | COR Cencora, Inc. | Mauch Robert P.46 | Executive Vice President &COO | Sell | 21,802 | $160.00 | $3,488,320.00 | -51.9% | -1.7% | +21.1% | |
| Nov 4, 2022 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 27,619 | $39.29 | $1,085,202.51 | -2.2% | -5.4% | -18.6% | |
| Nov 4, 2022 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 33,520 | $39.27 | $1,316,444.60 | -11.9% | -5.4% | -18.6% | |
| Nov 3, 2022 | HUM Humana Inc | Broussard Bruce D53 | President &CEO | Sell | 9,000 | $566.17 | $5,095,566.00 | -10.0% | -8.8% | -15.3% | |
| Nov 3, 2022 | CHE Chemed Corp | Westfall Nicholas Michael64 | Executive Vice President | Sell | 13,500 | $477.19 | $6,442,065.00 | -65.9% | +6.4% | +22.2% | |
| Nov 3, 2022 | CHE Chemed Corp | McNamara Kevin J57 | President And CEO | Sell | 2,000 | $482.90 | $965,800.00 | -1.6% | +6.4% | +22.2% | |
| Nov 3, 2022 | HUM Humana Inc | Fleming William Kevin48 | Seg Pres, Pharmacy Sol &Ccao | Sell | 11,157 | $565.61 | $6,310,550.94 | -81.4% | -8.8% | -15.3% | |
| Nov 3, 2022 | HUM Humana Inc | Diamond Susan M54 | Chief Financial Officer | Sell | 5,623 | $566.25 | $3,184,030.31 | -47.4% | -8.8% | -15.3% | |
| Nov 3, 2022 | HUM Humana Inc | Wheatley Timothy Alan | Segment President, Retail | Sell | 22,570 | $566.21 | $12,779,378.20 | -63.0% | -8.8% | -15.3% | |
| Nov 3, 2022 | HUM Humana Inc | Ventura Joseph C62 | Chief Legal Officer | Sell | 3,155 | $565.27 | $1,783,442.45 | -28.4% | -8.8% | -15.3% | |
| Nov 3, 2022 | CHE Chemed Corp | Witzeman Michael D | Vice President And Controller | Sell | 1,300 | $482.62 | $627,406.00 | -52.3% | +6.4% | +22.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.